‘Business as usual’ for GE Healthcare ahead of Danaher acquisition
‘We don’t want to change the way we work,’ says GE Healthcare Life Sciences CEO, as Danaher’s $21bn acquisition of the BioPharma business continues in the background.
Archives for June 17, 2019